Laobaixing Pharmacy (SHG:603883) — Market Cap & Net Worth
Market Cap & Net Worth: Laobaixing Pharmacy (603883)
Laobaixing Pharmacy (SHG:603883) has a market capitalization of $1.31 Billion (CN¥8.97 Billion) as of June 23, 2026. Listed on the SHG stock exchange, this China-based company holds position #7904 globally and #1887 in its home market, demonstrating a -0.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laobaixing Pharmacy's stock price CN¥11.82 by its total outstanding shares 758890236 (758.89 Million). Review Laobaixing Pharmacy debt and liabilities to assess the company's total debt and financial obligations.
Laobaixing Pharmacy Market Cap History: 2015 to 2026
Laobaixing Pharmacy's market capitalization history from 2015 to 2026. Data shows change from $4.00 Billion to $1.31 Billion (-7.00% CAGR).
Laobaixing Pharmacy Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Laobaixing Pharmacy's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Laobaixing Pharmacy's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.30x
Laobaixing Pharmacy's market cap is 4.30 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.65 Billion | $6.09 Billion | $296.90 Million | 0.43x | 8.92x |
| 2017 | $3.60 Billion | $7.50 Billion | $370.80 Million | 0.48x | 9.70x |
| 2018 | $2.73 Billion | $9.47 Billion | $435.04 Million | 0.29x | 6.28x |
| 2019 | $3.74 Billion | $11.66 Billion | $508.71 Million | 0.32x | 7.35x |
| 2020 | $5.16 Billion | $13.97 Billion | $621.09 Million | 0.37x | 8.31x |
| 2021 | $4.08 Billion | $15.70 Billion | $669.24 Million | 0.26x | 6.10x |
| 2022 | $4.42 Billion | $20.18 Billion | $784.96 Million | 0.22x | 5.63x |
| 2023 | $3.32 Billion | $22.44 Billion | $929.02 Million | 0.15x | 3.57x |
| 2024 | $1.82 Billion | $22.36 Billion | $519.06 Million | 0.08x | 3.50x |
| 2025 | $1.64 Billion | $22.24 Billion | $381.85 Million | 0.07x | 4.30x |
Competitor Companies of 603883 by Market Capitalization
Companies near Laobaixing Pharmacy in the global market cap rankings as of June 23, 2026.
Key companies related to Laobaixing Pharmacy by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1684 globally with a market cap of $14.55 Billion USD ( €12.44 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2202 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2575 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3350 globally with a market cap of $5.58 Billion USD ( R$28.41 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1684 | JD HEALTH INTL LTD | F:8ZN | $14.55 Billion | €3.88 |
| #2202 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2575 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3350 | Raia Drogasil S.A | SA:RADL3 | $5.58 Billion | R$16.25 |
Laobaixing Pharmacy Historical Marketcap From 2015 to 2026
Between 2015 and today, Laobaixing Pharmacy's market cap moved from $4.00 Billion to $ 1.31 Billion, with a yearly change of -7.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.31 Billion | -20.14% |
| 2025 | CN¥1.64 Billion | -9.59% |
| 2024 | CN¥1.82 Billion | -45.23% |
| 2023 | CN¥3.32 Billion | -24.83% |
| 2022 | CN¥4.42 Billion | +8.16% |
| 2021 | CN¥4.08 Billion | -20.89% |
| 2020 | CN¥5.16 Billion | +38.06% |
| 2019 | CN¥3.74 Billion | +36.89% |
| 2018 | CN¥2.73 Billion | -24.11% |
| 2017 | CN¥3.60 Billion | +35.89% |
| 2016 | CN¥2.65 Billion | -33.87% |
| 2015 | CN¥4.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Laobaixing Pharmacy was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.31 Billion USD |
| MoneyControl | $1.31 Billion USD |
| MarketWatch | $1.31 Billion USD |
| marketcap.company | $1.31 Billion USD |
| Reuters | $1.31 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Laobaixing Pharmacy
LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more